Top News

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through […]

Netflix Inc (NASDAQ:NFLX) shares are trading higher by 2.21% to $933.58 during Wednesday’s session. JPMorgan analyst Doug Anmuth raised his price target on the streaming giant from $850 to $1,010. What To Know: JPMorgan is raising their subscriber growth estimates for the fourth-quarter and beyond, driven by strong content, organic growth and an expanding ad-supported […]

Bitcoin miner MARA Holdings Inc (NASDAQ:MARA) recently completed its $850 million offering of 0% convertible senior notes due 2031. This happened soon after it completed a $1 billion offering of 0% convertible senior notes due 2030 in November. What Happened: The sale of the notes was completed in two days as the initial purchasers flocked […]

On Friday, Worksport Ltd (NASDAQ:WKSP) announced sales growth in its business-to-consumer (B2C) and business-to-business (B2B) segments for October and November 2024. The company said it saw improved gross margins, a key objective in its strategic shift to selling the higher-margin Worksport branded products exclusively and discontinuing all current lower-margin private label programs. CEO Steven Rossi […]

On CNBC’s “Mad Money Lightning Round,” Jim Cramer said Navitas Semiconductor Corporation (NASDAQ:NVTS) is “losing a lot of money.” On Tuesday, Navitas Semiconductor announced that Dr. Ranbir Singh, formerly executive vice president at Navitas and the founder and CEO of GeneSiC Semiconductor, has been appointed to the company’s board of directors. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) […]

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) saw its shares rise on Friday in the premarket session. Today, the company announced results from a Dose Range Finding (DRF) study for Probudur, its long-acting liposomal bupivacaine formulation. The study, conducted in minipigs, demonstrated that Probudur was well-tolerated with no adverse effects, supporting its potential for both immediate and extended […]

On CNBC’s “Mad Money Lightning Round,” Jim Cramer said Amphenol Corporation (NYSE:APH) is a “terrific” stock. On Oct. 23, Amphenol reported better-than-expected earnings for its fiscal third quarter. When asked about Freeport-McMoRan (NYSE:FCX), Cramer said he don’t like the copper stocks, and “copper doesn’t yield a lot here.” On Oct. 22, Freeport-McMoRan reported third-quarter FY24 […]

U.S. stocks settled lower on Friday, with the Dow Jones falling more than 300 points during the session. The S&P 500 recorded a weekly loss of 2.1%, while the Nasdaq Composite fell around 3.2%. The 30-stock Dow lost 1.2% during the week. Wall Street analysts make new stock picks on a daily basis. Unfortunately for […]

The World Health Organization (WHO) on Friday described vaccines as “absolutely critical” to global health, adding that many people alive today would not have survived childhood without them. This comes at after Donald Trump‘s announcement of Robert F. Kennedy Jr. as Health Secretary. What Happened: As per Benzinga Pro on Friday, health stocks declined further […]

On CNBC’s “Halftime Report Final Trades,” Bill Baruch of Blue Line Capital picked Microsoft Corporation (NASDAQ:MSFT), expecting it to outperform the Nasdaq between now and the end of the year. On Oct. 30, Microsoft reported first-quarter revenue of $65.60 billion, up 16% year-over-year. The total beat a Street consensus estimate of $64.51 billion according to […]